Abstract:Rationale: Previous translational studies implicate plasma extracellular microRNA-30d (miR-30d) as a biomarker in left ventricular remodeling and clinical outcome in heart failure (HF) patients, although precise mechanisms remain obscure. Objective: To investigate the mechanism of miR-30d-mediated cardioprotection in HF. Methods and results: In rat and mouse models of ischemic HF, we show that miR-30d gain of function (genetic, lentivirus, or agomiR-mediated) improves cardiac function, decreases myocardial fibrosis, and attenuates cardiomyocyte (CM) apoptosis. Genetic or locked nucleic acid-based knock-down of miR-30d expression potentiates pathological left ventricular remodeling, with increased dysfunction, fibrosis, and cardiomyocyte death. RNA sequencing of in vitro miR-30d gain and loss of function, together with bioinformatic prediction and experimental validation in cardiac myocytes and fibroblasts, were used to identify and validate direct targets of miR-30d. miR-30d expression is selectively enriched in cardiomyocytes, induced by hypoxic stress and is acutely protective, targeting MAP4K4 (mitogen-associate protein kinase 4) to ameliorate apoptosis. Moreover, miR-30d is secreted primarily in extracellular vesicles by cardiomyocytes and inhibits fibroblast proliferation and activation by directly targeting integrin α5 in the acute phase via paracrine signaling to cardiac fibroblasts. In the chronic phase of ischemic remodeling, lower expression of miR-30d in the heart and plasma extracellular vesicles is associated with adverse remodeling in rodent models and human subjects and is linked to whole-blood expression of genes implicated in fibrosis and inflammation, consistent with observations in model systems. Conclusions: These findings provide the mechanistic underpinning for the cardioprotective association of miR-30d in human HF. More broadly, our findings support an emerging paradigm involving intercellular communication of extracellular vesicle-contained miRNAs (microRNAs) to transregulate distinct signaling pathways across cell types. Functionally validated RNA biomarkers and their signaling networks may warrant further investigation as novel therapeutic targets in HF.

Pharmacological Silencing of MicroRNA-152 Prevents Pressure Overload–Induced Heart Failure

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.

Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy

Up-regulation of miR-155 protects against chronic heart failure by inhibiting HIF-1α

Over-expression of microRNA-145 drives alterations in β-adrenergic signaling and attenuates cardiac remodeling in heart failure post myocardial infarction

Analysis of Microrna Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure

Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling

MicroRNA‐150 Protects Against Pressure Overload‐Induced Cardiac Hypertrophy

Inhibition of Microrna-155 Ameliorates Cardiac Fibrosis in the Process of Angiotensin II-induced Cardiac Remodeling

Divergent cardiac and renal effects of miR-181c-5p inhibition in a rodent heart failure model

MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure

Abstract P3023: The Regulatory Role Of Mir-21 In Heart Failure With Preserved Ejection Fraction (hfpef)

In Vivo Suppression of Microrna-24 Prevents the Transition Toward Decompensated Hypertrophy in Aortic-Constricted Mice

Cardiomyocyte microRNA-150 confers cardiac protection and directly represses proapoptotic small proline–rich protein 1A

Microrna-210 As A Novel Therapy for Treatment of Ischemic Heart Disease

Role of microRNAs in cardiac hypertrophy and heart failure.

Silencing miR-370-3p rescues funny current and sinus node function in heart failure

Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.

Abstract 288: Mitoq Regulates Redox-related Non-coding Rnas to Improve Mitochondrial Network in Pressure Overload Heart Failure

MicroRNA-155 Inhibition Attenuates Endoplasmic Reticulum Stress-Induced Cardiomyocyte Apoptosis Following Myocardial Infarction Via Reducing Macrophage Inflammation